IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

NIGER, MONICA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.759
NA - Nord America 1.687
AS - Asia 1.464
SA - Sud America 167
AF - Africa 36
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.130
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.634
DE - Germania 841
CN - Cina 441
SG - Singapore 384
IT - Italia 232
GB - Regno Unito 220
BD - Bangladesh 201
HK - Hong Kong 144
BR - Brasile 140
SE - Svezia 98
VN - Vietnam 91
RU - Federazione Russa 84
FR - Francia 60
IN - India 55
IE - Irlanda 52
NL - Olanda 49
CA - Canada 40
FI - Finlandia 36
ID - Indonesia 26
TR - Turchia 25
JP - Giappone 23
CI - Costa d'Avorio 17
KR - Corea 16
ES - Italia 15
AT - Austria 13
AU - Australia 13
BE - Belgio 12
AR - Argentina 11
UA - Ucraina 11
PL - Polonia 10
MX - Messico 8
PK - Pakistan 8
ZA - Sudafrica 8
IQ - Iraq 6
TH - Thailandia 6
PH - Filippine 5
BO - Bolivia 4
CH - Svizzera 4
DK - Danimarca 4
IR - Iran 4
TW - Taiwan 4
EC - Ecuador 3
KE - Kenya 3
MA - Marocco 3
NO - Norvegia 3
NP - Nepal 3
NZ - Nuova Zelanda 3
PT - Portogallo 3
SA - Arabia Saudita 3
UZ - Uzbekistan 3
AZ - Azerbaigian 2
CO - Colombia 2
DZ - Algeria 2
HU - Ungheria 2
KZ - Kazakistan 2
LB - Libano 2
MV - Maldive 2
PY - Paraguay 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
BA - Bosnia-Erzegovina 1
BY - Bielorussia 1
CL - Cile 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
EG - Egitto 1
GF - Guiana Francese 1
GR - Grecia 1
HN - Honduras 1
IL - Israele 1
IS - Islanda 1
JM - Giamaica 1
JO - Giordania 1
KG - Kirghizistan 1
KW - Kuwait 1
LK - Sri Lanka 1
LT - Lituania 1
LU - Lussemburgo 1
LV - Lettonia 1
MO - Macao, regione amministrativa speciale della Cina 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
RO - Romania 1
SN - Senegal 1
TN - Tunisia 1
UY - Uruguay 1
VE - Venezuela 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 5.130
Salva come PNG Salva come JPEG
Città #
Frankfurt am Main 762
Ashburn 258
Singapore 193
Southend 165
Chandler 130
Hong Kong 125
San Jose 104
Dallas 101
Fairfield 89
Beijing 70
New York 69
Milan 55
Los Angeles 54
Dublin 52
Cambridge 49
Seattle 46
Woodbridge 44
Council Bluffs 41
Santa Clara 40
Wilmington 38
Houston 37
Ho Chi Minh City 33
Princeton 33
Hanoi 31
Munich 28
Dearborn 27
Ann Arbor 26
Hefei 26
Bengaluru 24
Jakarta 24
Buffalo 23
Moscow 21
Helsinki 20
Istanbul 20
Phoenix 20
Guangzhou 18
Lauterbourg 18
Nanjing 18
Abidjan 17
Shanghai 15
Toronto 15
Des Moines 14
Boardman 13
Tokyo 13
Brussels 12
Cangzhou 11
Naples 11
Rome 11
São Paulo 11
Columbus 10
Redwood City 10
The Dalles 10
Chicago 9
London 8
Seoul 8
Shenyang 8
Tianjin 8
Turku 8
Fuzhou 7
Hangzhou 7
Orem 7
Warsaw 7
Zhengzhou 7
Amsterdam 6
Atlanta 6
Bexley 6
Falls Church 6
Grafing 6
Haikou 6
Montreal 6
Mountain View 6
Nuremberg 6
Quanzhou 6
Rochester 6
San Diego 6
Silver Spring 6
Vienna 6
Wuhan 6
Central District 5
Changsha 5
Erlangen 5
Hyderabad 5
Jinan 5
Johannesburg 5
Oxford 5
Palermo 5
Sydney 5
Washington 5
Ascoli Piceno 4
Bari 4
Belo Horizonte 4
Berlin 4
Brasília 4
Brescia 4
Bühl 4
Denver 4
Eitensheim 4
Gainesville 4
Genoa 4
Manchester 4
Totale 3.377
Salva come PNG Salva come JPEG
Nome #
Prognostic impact of ATM mutations in patients with metastatic colorectal cancer 370
Undetected toxicity risk in pharmacogenetic testing for dihydropyrimidine dehydrogenase 342
GNAS mutations as prognostic biomarker in patients with relapsed peritoneal pseudomyxoma receiving metronomic capecitabine and bevacizumab : A clinical and translational study 341
Assessment of Ramucirumab plus paclitaxel as switch maintenance versus continuation of first-line chemotherapy in patients with advanced HER-2 negative gastric or gastroesophageal junction cancers: the ARMANI phase III trial 341
Comparative Effectiveness of Gemcitabine plus Nab-Paclitaxel and FOLFIRINOX in the First-Line Setting of Metastatic Pancreatic Cancer: A Systematic Review and Meta-Analysis 334
Metronomic Capecitabine With Cyclophosphamide Regimen in Unresectable or Relapsed Pseudomyxoma Peritonei 288
MGMT inactivation as a new biomarker in patients with advanced biliary tract cancers 263
Maintenance Therapy with Panitumumab Alone vs Panitumumab Plus Fluorouracil-Leucovorin in Patients with RAS Wild-Type Metastatic Colorectal Cancer: A Phase 2 Randomized Clinical Trial 262
Targeting the PI3K/AKT/mTOR pathway in biliary tract cancers: A review of current evidences and future perspectives 261
Emergence of MET hyper-amplification at progression to MET and BRAF inhibition in colorectal cancer 258
Ramucirumab as Second-Line Therapy in Metastatic Gastric Cancer : Real-World Data from the RAMoss Study 235
Safety of long-term exposure to abiraterone acetate in patients with castration-resistant prostate cancer and concomitant cardiovascular risk factors 227
BRAF in metastatic colorectal cancer : the future starts now 214
Management of BRCA Tumour Testing in an Integrated Molecular Tumour Board Multidisciplinary Model 210
Preoperative Capecitabine, Oxaliplatin, and Irinotecan in Resectable Gastric or Gastroesophageal Junction Cancer: Pathological Response as Primary Endpoint and FDG-PET Predictions 199
FOLFOXIRI-Bevacizumab or FOLFOX-Panitumumab in Patients with Left-Sided RAS/BRAF Wild-Type Metastatic Colorectal Cancer: A Propensity Score-Based Analysis 196
Prognostic Role of a New Index Tested in European and Korean Advanced Biliary Tract Cancer Patients: the PECS Index 190
A new nomogram for estimating survival in patients with brain metastases secondary to colorectal cancer 184
Progress in treatments for colorectal cancer peritoneal metastases during the years 2010-2015 : a systematic review 177
Safety and antitumor activity of metformin plus lanreotide in patients with advanced gastro-intestinal or lung neuroendocrine tumors: the phase Ib trial MetNET2 151
Outpatient palliative care referral system (PCRS) for patients with advanced cancer: an impact evaluation protocol 149
The potential role of metformin in the treatment of patients with pancreatic neuroendocrine tumors: a review of preclinical to clinical evidence 87
null 3
null 1
Totale 5.283
Salva come PNG Salva come JPEG
Categoria #
all - tutte 12.529
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.529
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202117 0 0 0 0 0 0 0 0 0 0 0 17
2021/2022266 27 10 11 23 18 18 9 18 19 34 14 65
2022/2023401 57 52 41 32 35 78 9 18 46 7 21 5
2023/2024765 7 14 17 25 88 22 106 105 53 103 114 111
2024/20251.042 95 111 85 121 57 48 79 64 40 98 82 162
2025/20261.913 186 144 177 114 136 90 215 57 157 118 266 253
Totale 5.283